Sasan Sakiani, MD

Medical School

• Ross University School of Medicine, 2008

Post-Graduate Research

• Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health

Residency

• Case Western Reserve University - MetroHealth Medical Center, 2012

Fellowship

• Cleveland Clinic - Transplant Hepatology, 2018
• Case Western Reserve University - MetroHealth Medical Center, 2015

Certifications

• American Board of Internal Medicine - Transplant Hepatology, 2018
• American Board of Internal Medicine - Gastroenterology, 2015
• American Board of Internal Medicine - Internal Medicine, 2012

Dr. Sakiani is an assistant professor of medicine and is board certified in internal medicine, gastroenterology, and transplant hepatology. He completed his transplant hepatology training at Cleveland Clinic in Cleveland, Ohio and is currently part of the transplant hepatology team at the University of Maryland Medical Center. Prior to this, he served as co-Director of Hepatology at MetroHealth Medical Center in Cleveland, Ohio.

Dr. Sakiani has clinical expertise in the management of liver transplant patients, as well as viral hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, and cirrhosis of the liver. In addition, he has a special interest in cystic fibrosis liver disease and has published his research performed in collaboration with the National Institutes of Health. 

He remains an active member of the American Association for the Study of Liver Disease (AASLD), the American Gastroenterology Association (AGA), and the American College of Gastroenterology (ACG).

Transplant Hepatology, Non-alcoholic fatty liver disease (NAFLD), Non-alcoholic steatohepatitis (NASH), Cirrhosis, Viral Hepatitis, Hepatitis C, Hepatitis B, Cystic Fibrosis Liver Disease.

Peer-reviewed journal articles

Hara K, Rivera MM, Koh C, Sakiani S, Hoofnagle JH, Heller T. Important Factors in Reliable Determination of Hepatitis C Virus Genotype using the 5’ Untranslated Region. J. Clin. Microbiol, 2013, May; 51(5):1485-9

Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar J. The American Association for the Study of Liv Diseases (AASLD) Clinical Practice Guidelines: A Critical Review of Scientific Evidence and Evolving Recommendations.  Hepatology, 2013, Dec; 58(6):2142-52

Sakiani S, Koh C, Heller T. Understanding the Presence of False Positive Antibodies in Acute Hepatitis. J Infect Dis. 2014 Dec 15; 210(12):1886-9

Sakiani S, Koh C, Heller T. Reply to Tennant and Post. J Infect Dis. 2016 Jan 15; 213(2):325-6

Koh C*, Sakiani S*, Surana P, Zhao X, Eccleston J, Kleiner DE, Herion D, Liang TJ, Hoofnagle JH, Chernick M, Heller T. Adult Onset Cystic Fibrosis Liver Disease: Diagnosis and characterization of an underappreciated entity. Hepatology. 2017 Aug; 66(2):591-601
*denotes co-first authorship

Koh C*, Sakiani S*, Heller T. Reply: Cystic Fibrosis Liver Disease in Adults: limits of non-invasive tests of fibrosis. Hepatology. 2017 Nov 3
*denotes co-first authorship

Sakiani S, Kleiner DE, Heller T, Koh C. Hepatic Manifestations of Cystic Fibrosis. Clin Liver Dis. 2019 May;23(2):263-277

Book Chapters

Chapter on Acute Alcoholic Hepatitis, Cohen S, Davitkov P. (2019) Liver Disease – A Clinical Casebook. Springer